Scholar Rock Holding Analyst Ratings
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Analysts' Top Healthcare Picks: Scholar Rock Holding (SRRK), Gilead Sciences (GILD)
Scholar Rock Holding (SRRK) Receives a Buy From Truist Financial
Buy Rating Affirmed for Scholar Rock Holding on Strong Drug Pipeline and Market Readiness
HC Wainwright & Co. : The Scholar Rock Holding (SRRK.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $30.00.
Scholar Rock Holding Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Scholar Rock Holding Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Buy Rating Justified by Scholar Rock's Promising Pipeline and Strategic Clinical Advancements
Analysts Are Bullish on Top Healthcare Stocks: Scholar Rock Holding (SRRK), Zimmer Biomet Holdings (ZBH)
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding Analyst Ratings
Piper Sandler Remains a Buy on Scholar Rock Holding (SRRK)
Scholar Rock Holding Analyst Ratings
Truist Securities Reiterates Buy on Scholar Rock Holding, Maintains $20 Price Target
Buy Rating Affirmed for Scholar Rock on Strong SMA Pipeline and Strategic Developments
No Data